CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 142 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,307 | +215.4% | 423 | -4.3% | 0.00% | – |
| Q1 2022 | $2,000 | 0.0% | 442 | 0.0% | 0.00% | – |
| Q4 2021 | $2,000 | 0.0% | 442 | 0.0% | 0.00% | – |
| Q3 2021 | $2,000 | 0.0% | 442 | 0.0% | 0.00% | – |
| Q2 2021 | $2,000 | 0.0% | 442 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | 0.0% | 442 | 0.0% | 0.00% | – |
| Q4 2020 | $2,000 | -50.0% | 442 | 0.0% | 0.00% | – |
| Q3 2020 | $4,000 | +100.0% | 442 | 0.0% | 0.00% | – |
| Q2 2020 | $2,000 | – | 442 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 442 | -21.6% | 0.00% | – |
| Q4 2019 | $2,000 | – | 564 | +1466.7% | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 36 | -99.6% | 0.00% | – |
| Q1 2019 | $136,000 | +30.8% | 10,260 | -21.8% | 0.00% | – |
| Q4 2018 | $104,000 | -11.9% | 13,120 | +23.1% | 0.00% | – |
| Q3 2018 | $118,000 | -22.4% | 10,660 | -6.2% | 0.00% | – |
| Q2 2018 | $152,000 | – | 11,360 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,641,804 | $11,887,000 | 8.85% |
| Foresite Capital Management IV, LLC | 1,787,094 | $12,939,000 | 2.92% |
| Copernicus Capital Management, LLC | 278,416 | $2,016,000 | 1.92% |
| Sio Capital Management, LLC | 1,159,236 | $8,393,000 | 1.66% |
| ACUTA CAPITAL PARTNERS, LLC | 765,000 | $5,539,000 | 1.50% |
| Avoro Capital Advisors LLC | 10,300,000 | $74,572,000 | 1.06% |
| Boxer Capital, LLC | 4,000,000 | $28,960,000 | 1.00% |
| Vivo Capital, LLC | 2,089,356 | $15,127,000 | 0.87% |
| EAM Global Investors LLC | 284,534 | $2,060,000 | 0.76% |
| Versant Venture Management, LLC | 543,753 | $3,937,000 | 0.72% |